Related Experiment Video

Updated: Jul 3, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

PPAR-gamma: Therapeutic Potential for Multiple Sclerosis

Paul D Drew1, Jihong Xu, Michael K Racke

  • 1Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Biomedical Research Building II, Room 563-2, 4301 W. Markham Street, Little Rock, AR 72205, USA.

PPAR Research
|July 8, 2008
PubMed

Insights

Peroxisome proliferator-activated receptors (PPARs) influence immune responses. PPAR-gamma agonists show potential in treating multiple sclerosis by modulating experimental autoimmune encephalomyelitis.

Area of Science:

  • Immunology and Metabolism
  • Neuroscience

Background:

  • Peroxisome proliferator-activated receptors (PPARs) are known regulators of lipid and glucose metabolism.
  • Emerging research highlights their significant role in modulating immune system functions.
  • Previous studies have shown that PPAR-gamma agonists impact experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS).

Purpose of the Study:

  • To review the cellular and molecular mechanisms underlying PPAR-gamma agonist effects in EAE.
  • To explore the therapeutic potential of PPAR-gamma agonists for multiple sclerosis treatment.

Main Methods:

  • Literature review of studies on PPARs, EAE, and multiple sclerosis.
  • Analysis of cellular and molecular pathways involved in PPAR-mediated immune modulation.

Main Results:

  • PPAR-gamma agonists have demonstrated a capacity to modulate the progression of experimental autoimmune encephalomyelitis.
  • Understanding the mechanisms of action provides insights into immune regulation.

Conclusions:

  • PPAR-gamma agonists represent a promising therapeutic avenue for multiple sclerosis.
  • Further research into the specific mechanisms could optimize treatment strategies for autoimmune diseases.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...